ChristopherGravesGoetzMD

Professor of neurological sciences and pharmacology at Rush University Medical Center in Chicago and serves as director of the movement disorders program; United Parkinson Foundation Professor of Neurology

Join to view full profile

Dr. Goetz is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Goetz's full profile

Already have an account?

Office
1725 W Harrison
#755 Neuroscience Institute Sect Of Movement Disorders
Chicago, IL 60612
Phone+1 312-563-2030

Fax+1 312-563-2684
Is this information wrong?

Education & Training

Rush University Medical CenterResidency, Neurology, 1977 - 1979
Michael Reese Hospital and Medical CenterResidency, Neurology, 1976 - 1977
Rush University Medical CenterInternship, Transitional Year, 1975 - 1976
Rush Medical College of Rush University Medical CenterClass of 1975

Certifications & Licensure

IL State Medical License 1976 - 2026
American Board of Psychiatry and Neurology Neurology

Awards, Honors, & Recognition

America's Top Doctors Castle Connolly, 2002-2014
Chicago Magazine: Top Doctors Castle Connolly, 2004, 2006, 2008, 2010, 2012, 2014
CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2013
Super Doctor SuperDoctors.com
Join now to see all

Clinical Trials

Validation of Dyskinesia Rating Scales Start of enrollment: 2010 Jan 01
Completed
Phase 4
The Dystonia Coalition Natural History and Biospecimen Repository for Isolated Dystonias Start of enrollment: 2011 Jan 01
Completed
Topiramate as an Adjunct to Amantadine in the Treatment of Dyskinesia in Parkinson's Disease Start of enrollment: 2013 Mar 01
Terminated
Phase 2
Fixed-Dose Trial in Early Parkinson's Disease (PD) Start of enrollment: 2019 Dec 13
Active, not recruiting
Phase 3
Roles: Contact
Join now to see all

Publications & Presentations

PubMed

Co-Existent Probable RBD and PD: Disease Progression, Medication Response, and Clinical Trial Implications.
Haotian Zou, Yuanyuan Guo, Christopher G Goetz, Tiago A Mestre, Glenn T Stebbins, Falah Al-Hajraf, Michael Lawton, Michele Hu, Sheng Luo> ;Movement Disorders Clinical Practice. 2024 Mar 1
1 citations
Patient With Parkinson Disease and Care Partner Perceptions of Key Domains Affecting Health-Related Quality of Life: Systematic Review
Michelle H Tosin, Christopher G Goetz, Glenn T Stebbins> ;Neurology. 2024 Feb 13
1 citations
NIH Toolbox performance of persons with Parkinson's disease according to GBA1 and STN-DBS status.
Ahmad Almelegy, Srujanesh Gunda, Steven Buyske, Marc Rosenbaum, Sepehr Sani, Mitra Afshari, Leo V Metman, Christopher G Goetz, Deborah Hall, M Maral Mouradian, Gian Pal> ;Annals of Clinical and Translational Neurology. 2024 Apr 1
A Novel Home-Based Telerehabilitation Program Targeting Fall Prevention in Parkinson Disease: A Preliminary Trial.
Hernandez, A., Joyce, J., Hauptschein, A., Trenkle, K., Stebbins, G., Afshari, M., Goetz, C.> ;Neurology. Clinical Practice. 2024 Feb 1
Unveiling Assessment Gaps in Parkinson's Disease Psychosis: A Scoping Review.
Graziella Mangone, Michelle H S Tosin, Christopher G Goetz, Glenn T Stebbins, Tiago A Mestre> ;Movement Disorders. 2024 Mar 1
Validation of the Kazakh version of the movement disorder Society-Unified Parkinson's disease rating scale.
Abdraimova, S., Myrzayev, Z., Karimova, A., Talgatkyzy, A., Khaibullin, T., Kaishibayeva, G., Elubaeva, S., Esembekova, K., Choi, D., Martinez-Martin, P., Stebbins, G....> ;Clinical Parkinsonism & Related Disorders. 2024 Jan 1
Reply to a Letter to the Editor Entitled "Comment: The Rush Video-Based Tic Rating Scale-Revised: A Practice-Oriented Revision" Responding to our Paper "the Rush Video...
Müller-Vahl, K., Riechmann, R., Jakubovski, E., Essing, J., Haas, M., Stebbins, G., Goetz, C.> ;Movement Disorders Clinical Practice. 2024 Jan 1
8 citations
A Statement of the MDS on Biological Definition, Staging, and Classification of Parkinson's Disease.
Cardoso, F., Goetz, C., Mestre, T., Sampaio, C., Adler, C., Berg, D., Bloem, B., Burn, D., Fitts, M., Gasser, T., Klein, C., de Tijssen, M., Lang, A., Lim, S., Litvan,...> ;Movement Disorders. 2024 Feb 1
Assessing the Severity of Cervical Dystonia: Ask the Doctor or Ask the Patient?
Adam C Cotton, Laura Scorr, William McDonald, Cynthia Comella, Joel S Perlmutter, Christopher G Goetz, Joseph Jankovic, Laura Marsh, Stewart Factor, H A Jinnah> ;Movement Disorders Clinical Practice. 2023 Sep 1
Reply to: "The Framework for Diagnostic Criteria in Movement Disorders: The Value of Methodological Tools and Combined Criteria".
Tiago A Mestre, Sheng Luo, Glenn T Stebbins, Cristina Sampaio, Christopher G Goetz> ;Movement Disorders. 2023 Sep 1
1 citations
Reply to: Comment on "Summing MDS-UPDRS Parts 1 + 2 (Non-motor and Motor Experience of Daily Living): The Patient's Voice".
Christopher G Goetz, Haotian Zou, Glenn T Stebbins, Anette Schrag, Tiago A Mestre, Sheng Luo> ;Movement Disorders. 2023 Aug 1
2 citations
A Unified Framework for Evidence-Based Diagnostic Criteria Programs in Movement Disorders.
Tiago A Mestre, Margherita Fabbri, Sheng Luo, Glenn T Stebbins, Christopher G Goetz, Cristina Sampaio> ;Movement Disorders. 2023 Jul 1
2 citations
The Rush Video-Based Tic Rating Scale-Revised: A Practice-Oriented Revision.
Rica Riechmann, Ewgeni Jakubovski, Jana Essing, Martina Haas, Christopher G Goetz, Glenn T Stebbins, Kirsten R Müller-Vahl> ;Movement Disorders Clinical Practice. 2023 May 1
2 citations
Summing MDS-UPDRS Parts 1 + 2 (Non-motor and Motor Experience of Daily Living): The Patient's Voice.
Haotian Zou, Christopher G Goetz, Glenn T Stebbins, Anette Schrag, Tiago A Mestre, Sheng Luo> ;Movement Disorders. 2023 Jul 1
1 citations
Genetics of Neurogenic Orthostatic Hypotension in Parkinson's Disease, Results from a Cross-Sectional In Silico Study.
Guenson Chevalier, Lucas Udovin, Matilde Otero-Losada, Sofia Bordet, Francisco Capani, Sheng Luo, Christopher G Goetz, Santiago Perez-Lloret> ;Brain Sciences. 2023 Mar 17
11 citations
An open label, non-randomized study assessing a prebiotic fiber intervention in a small cohort of Parkinson's disease participants.
Deborah A Hall, Robin M Voigt, Thaisa M Cantu-Jungles, Bruce Hamaker, Phillip A Engen, Maliha Shaikh, Shohreh Raeisi, Stefan J Green, Ankur Naqib, Christopher B Forsyt...> ;Nature Communications. 2023 Feb 18
Rating Scales for Medication Adherence in Parkinson's Disease: A Systematic Review for Critique and Recommendations.
Michelle H S Tosin, Beatriz Guitton R B de Oliveira, Christopher G Goetz, Donald Morisky, Victor McConvey, Matej Skorvanek, Anette Schrag, Pablo Martinez-Martin, Glenn...> ;Movement Disorders Clinical Practice. 2023 Feb 1
1 citations
Cross-Cultural Differences in Patient Perceptions of Dyskinesia in Parkinson's Disease.
Valtteri Kaasinen, Sheng Luo, Pablo Martinez-Martin, Christopher G Goetz, Glenn T Stebbins> ;Movement Disorders. 2023 Apr 1
4 citations
Using Movement Disorder Society Unified Parkinson's Disease Rating Scale Parts 2 and 3 Simultaneously: Combining the Patient Voice with Clinician Ratings.
Yuanyuan Guo, Christopher G Goetz, Glenn T Stebbins, Tiago A Mestre, Sheng Luo> ;Movement Disorders. 2023 Mar 1
6 citations
It Is as It Was: MDS-UPDRS Part III Scores Cannot Be Combined with Other Parts to Give a Valid Sum.
Christopher G Goetz, Dongrak Choi, Yuanyuan Guo, Glenn T Stebbins, Tiago A Mestre, Sheng Luo> ;Movement Disorders. 2023 Feb 1
1 citations
The plight of loneliness in Parkinson's disease: New opportunities.
David Andrés González, Michelle Hyczy de Siqueira Tosin, Christopher G Goetz> ;Parkinsonism & Related Disorders. 2022 Dec 1
2 citations
Movement Disorder Society Unified Parkinson's Disease Rating Scale Motor Examination Retains Its 2-Domain Profile in BothandStates.
Yuanyuan Guo, Glenn T Stebbins, Tiago A Mestre, Christopher G Goetz, Sheng Luo> ;Movement Disorders Clinical Practice. 2022 Nov 1
6 citations
Disproportionality analysis of adverse neurological and psychiatric reactions with the ChAdOx1 (Oxford-AstraZeneca) and BNT162b2 (Pfizer-BioNTech) COVID-19 vaccines in...
Matilde Otero-Losada, Nikolai Petrovsky, Abdallah Alami, James A Crispo, Donald Mattison, Francisco Capani, Christopher Goetz, Daniel Krewski, Santiago Perez-Lloret> ;Expert Opinion on Drug Safety. 2023 Apr 1
3 citations
Are Virtual Objective Assessments of Fall-Risk Feasible and Safe for People with Parkinson's Disease?
Mitra Afshari, Andrea V Hernandez, Jorik Nonnekes, Bastiaan R Bloem, Christopher G Goetz> ;Movement Disorders Clinical Practice. 2022 Aug 1
2 citations
Resolving Missing Data from the Movement Disorder Society Unified Parkinson's Disease Rating Scale: Implications for Telemedicine.
Sheng Luo, Christopher G Goetz, Dongrak Choi, Sanket Aggarwal, Tiago A Mestre, Glenn T Stebbins> ;Movement Disorders. 2022 Aug 1
Join now to see all

Press Mentions

Apathy, Impulse Control Disorders Coexist in Parkinson’s DiseaseOctober 8th, 2020
Man’s Unlikely Approach for Parkinson’s Disease? Stand up ComedyJanuary 16th, 2020
How Rush Medical Uses Telehealth to Treat Parkinson's DiseaseAugust 30th, 2017
Join now to see all